Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway

  • Authors:
    • Linlin Lu
    • Shousheng Liu
    • Quanjiang Dong
    • Yongning Xin
  • View Affiliations

  • Published online on: April 2, 2019     https://doi.org/10.3892/mmr.2019.10115
  • Pages: 4964-4972
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Salidroside (SDS) is a phenylpropanoid glycoside isolated from Rhodiola rosea L. It exhibits multiple pharmacological properties in clinical medicine and has been commonly used in traditional Chinese medicine. The present study investigated the inhibitory effects of SDS on tumor invasion and migration, and the expression of metastasis‑related genes in highly metastatic hepatocellular carcinoma (HCC) cells (MHCC97H) in vitro. The underlying mechanisms of SDS on the tumor metastasis were also explored. SDS was found to significantly reduce wound closure areas and inhibit cell migration. In addition, SDS markedly inhibited the invasion of these cells into Matrigel‑coated membranes. SDS markedly downregulated the expression of Notch1, Snail, COX‑2, MMP‑2, MMP‑9 genes and upregulated the expression of E‑cadherin in a dose‑dependent manner. Furthermore, SDS inhibited the expression of the Notch signaling target genes, Hey1, Hes1 and Hes5. On the whole, the findings of this study suggest that SDS inhibits HCC cell metastasis by modulating the activity of the Notch1 signaling pathway.

References

1 

Cabibbo G, Latteri F, Antonucci M and Craxì A: Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol. 6:159–169. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Singh S, Singh PP, Roberts LR and Sanchez W: Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 11:45–54. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Dutta R and Mahato RI: Recent advances in hepatocellular carcinoma therapy. Pharmacol Ther. 173:106–117. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Yu Q, Liu ZY, Chen Q and Lin JS: Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma. J Huazhong Univ Sci Technolog Med Sci. 36:494–500. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Khanna K, Mishra KP, Ganju L and Singh SB: Golden root: A wholesome treat of immunity. Biomed Pharmacother. 87:496–502. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Hu X, Lin S, Yu D, Qiu S, Zhang X and Mei R: A preliminary study: The anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol Toxicol. 26:499–507. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Schriner SE, Abrahamyan A, Avanessian A, Bussel I, Maler S, Gazarian M, Holmbeck MA and Jafari M: Decreased mitochondrial superoxide levels and enhanced protection against paraquat in Drosophila melanogaster supplemented with Rhodiola rosea. Free Radic Res. 43:836–843. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Zhang L, Yu H, Sun Y, Lin X, Chen B, Tan C, Cao G and Wang Z: Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol. 564:18–25. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Goel HC, Bala M, Prasad J, Singh S, Agrawala PK and Swahney RC: Radioprotection by Rhodiola imbricata in mice against whole-body lethal irradiation. J Med Food. 9:154–160. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Perfumi M and Mattioli L: Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res. 21:37–43. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Spasov AA, Wikman GK, Mandrikov VB, Mironova IA and Neumoin VV: A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. 7:85–89. 2000. View Article : Google Scholar : PubMed/NCBI

12 

Mishra KP, Padwad YS, Dutta A, Ganju L, Sairam M, Banerjee PK and Sawhney RC: Aqueous extract of Rhodiola imbricata rhizome inhibits proliferation of an erythroleukemic cell line K-562 by inducing apoptosis and cell cycle arrest at G2/M phase. Immunobiology. 213:125–131. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Kang DZ, Hong HD, Kim KI and Choi SY: Anti-fatigue effects of fermented Rhodiola rosea extract in mice. Prev Nutr Food Sci. 20:38–42. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Tao K, Wang B, Feng D, Zhang W, Lu F, Lai J, Huang L, Nie T and Yang Q: Salidroside protects against 6-hydroxydopamine-induced cytotoxicity by attenuating ER stress. Neurosci Bull. 32:61–69. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Zhang Y, Yao Y, Wang H, Guo Y, Zhang H and Chen L: Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. Chin J Cancer Res. 25:520–526. 2013.PubMed/NCBI

16 

Wang H, Ding Y, Zhou J, Sun X and Wang S: The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine. 16:146–155. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S and Towers GH: Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res. 19:740–743. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Wang J, Li JZ, Lu AX, Zhang KF and Li BJ: Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression. Oncol Lett. 7:1159–1164. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Hu X, Zhang X, Qiu S, Yu D and Lin S: Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem Biophys Res Commun. 398:62–67. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Fan XJ, Wang Y, Wang L and Zhu M: Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol Rep. 36:3559–3567. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Senthilkumar R, Parimelazhagan T, Chaurasia OP and Srivastava RB: Free radical scavenging property and antiproliferative activity of Rhodiola imbricata Edgew extracts in HT-29 human colon cancer cells. Asian Pac J Trop Med. 6:11–19. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Zhao G, Shi A, Fan Z and Du Y: Salidroside inhibits the growth of human breast cancer in vitro and in vivo. Oncol Rep. 33:2553–2560. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Sun C, Wang Z, Zheng Q and Zhang H: Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells. Phytomedicine. 19:355–363. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Gao J, Song Z, Chen Y, Xia L, Wang J, Fan R, Du R, Zhang F, Hong L, Song J, et al: Deregulated expression of Notch receptors in human hepatocellular carcinoma. Dig Liver Dis. 40:114–121. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC, Clevers H, Dotto GP and Radtke F: Notch1 functions as a tumor suppressor in mouse skin. Nat Genet. 33:416–421. 2003. View Article : Google Scholar : PubMed/NCBI

26 

Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 61:3200–3205. 2001.PubMed/NCBI

27 

Jang MS, Zlobin A, Kast WM and Miele L: Notch signaling as a target in multimodality cancer therapy. Curr Opin Mol Ther. 2:55–65. 2000.PubMed/NCBI

28 

Ma YC, Shi C, Zhang YN, Wang LG, Liu H, Jia HT, Zhang YX, Sarkar FH and Wang ZS: The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells. PloS One. 7:e334142012. View Article : Google Scholar : PubMed/NCBI

29 

Yu B, Wei J, Qian X, Lei D, Ma Q and Liu Y: Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma. Oncol Rep. 27:547–552. 2012.PubMed/NCBI

30 

Wang J, Fu L, Gu F and Ma Y: Notch1 is involved in migration and invasion of human breast cancer cells. Oncol Rep. 26:1295–1303. 2011.PubMed/NCBI

31 

Zhou L, Zhang N, Li QJ, Sun W, Zhang Y, Wang DS and Dou KF: Associations between high levels of Notch1 expression and high invasion and poor overall survival in hepatocellular carcinoma. Tumour Biol. 34:543–553. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and Dou KF: Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and −9 and vascular endothelial growth factor. Oncol Rep. 28:874–882. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Sahlgren C, Gustafsson MV, Jin S, Poellinger L and Lendahl U: Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA. 105:6392–6397. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu X, Sun J, Yang S, Poon RT and Fan ST: Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma. Int J Cancer. 131:E163–E172. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Lim SO, Kim HS, Quan X, Ahn SM, Kim H, Hsieh D, Seong JK and Jung G: Notch1 binds and induces degradation of Snail in hepatocellular carcinoma. BMC Biol. 9:832011. View Article : Google Scholar : PubMed/NCBI

36 

Lim SO, Park YM, Kim HS, Quan X, Yoo JE, Park YN, Choi GH and Jung G: Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology. 53:1352–1362. 2011. View Article : Google Scholar : PubMed/NCBI

37 

Khamis ZI, Iczkowski KA and Sang QXA: Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: Their prospects as therapeutic agents. Med Res Rev. 32:1026–1077. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Debruyne P, Vermeulen S and Mareel M: The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg. 62:393–402. 1999.PubMed/NCBI

39 

Mareel M, Vleminckx K, Vermeulen S, Yan G, Bracke M and van Roy F: Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer. Princess Takamatsu Symp. 24:63–80. 1994.PubMed/NCBI

40 

Vihinen P and Kähäri VM: Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI

41 

Curran S and Murray GI: Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000. View Article : Google Scholar : PubMed/NCBI

42 

Stetler-Stevenson WG: The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am. 10:383–392. 2001. View Article : Google Scholar : PubMed/NCBI

43 

Weis M, Heeschen C, Glassford AJ and Cooke JP: Statins have biphasic effects on angiogenesis. Circulation. 105:739–745. 2002. View Article : Google Scholar : PubMed/NCBI

44 

Wu HM, Zhu SL, He LJ, Liu YH and Xie D: Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer. Chin J Cancer. 28:1054–1060. 2009.[Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer]. View Article : Google Scholar

45 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

46 

Wang Y, Shi J, Chai K, Ying X and Zhou BP: The role of Snail in EMT and tumorigenesis. Curr Cancer Drug Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI

47 

Qu L and Liu B: Cyclooxygeanse-2 promotes metastasis in osteosarcoma. Cancer Cell Int. 15:692015. View Article : Google Scholar : PubMed/NCBI

48 

Onder TT, Gupta PB, Mani SA, Yang J, Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI

49 

Wieland E, Rodriguez-Vita J, Liebler SS, Mogler C, Moll I, Herberich SE, Espinet E, Herpel E, Menuchin A, Chang-Claude J, et al: Endothelial Notch1 activity facilitates metastasis. Cancer Cell. 31:355–367. 2017. View Article : Google Scholar : PubMed/NCBI

50 

Egan SE, St-Pierre B and Leow CC: Notch receptors, partners and regulators: From conserved domains to powerful functions. Curr Top Microbiol Immunol. 228:273–324. 1998.PubMed/NCBI

51 

Callahan R and Egan SE: Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia. 9:145–163. 2004. View Article : Google Scholar : PubMed/NCBI

52 

Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G and Egan SE: High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 65:8530–8537. 2005. View Article : Google Scholar : PubMed/NCBI

53 

Chu D, Li Y, Wang W, Zhao Q, Li J, Lu Y, Li M, Dong G, Zhang H, Xie H and Ji G: High level of Notch1 protein is associated with poor overall survival in colorectal cancer. Ann Surg Oncol. 17:1337–1342. 2010. View Article : Google Scholar : PubMed/NCBI

54 

Makrilia N, Kollias A, Manolopoulos L and Syrigos K: Cell adhesion molecules: Role and clinical significance in cancer. Cancer Invest. 27:1023–1037. 2009. View Article : Google Scholar : PubMed/NCBI

55 

Mareel M, Vleminckx K, Vermeulen S, Bracke M and Van Roy F: E-cadherin expression: A counterbalance for cancer cell invasion. Bull Cancer. 79:347–355. 1992.PubMed/NCBI

56 

Shimada T, Nakamura H, Yamashita K, Kawata R, Murakami Y, Fujimoto N, Sato H, Seiki M and Okada Y: Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis. Clin Exp Metastasis. 18:179–188. 2000. View Article : Google Scholar : PubMed/NCBI

57 

Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J and Tiwari RK: Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in thyroid cancer. PLoS One. 6:e158792011. View Article : Google Scholar : PubMed/NCBI

58 

Yan L, Lin B, Gao L, Gao S, Liu C, Wang C, Wang Y, Zhang S and Iwamori M: Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells. Int J Mol Sci. 11:4441–4452. 2010. View Article : Google Scholar : PubMed/NCBI

59 

Murphy AN, Unsworth EJ and Stetler-Stevenson WG: Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol. 157:351–358. 1993. View Article : Google Scholar : PubMed/NCBI

60 

Zhao HB, Qi SN, Dong JZ, Ha XQ, Li XY, Zhang QW, Yang YS, Bai J and Zhao L: Salidroside induces neuronal differentiation of mouse mesenchymal stem cells through Notch and BMP signaling pathways. Food Chem Toxicol. 71:60–67. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 19 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Lu, L., Liu, S., Dong, Q., & Xin, Y. (2019). Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway. Molecular Medicine Reports, 19, 4964-4972. https://doi.org/10.3892/mmr.2019.10115
MLA
Lu, L., Liu, S., Dong, Q., Xin, Y."Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway". Molecular Medicine Reports 19.6 (2019): 4964-4972.
Chicago
Lu, L., Liu, S., Dong, Q., Xin, Y."Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway". Molecular Medicine Reports 19, no. 6 (2019): 4964-4972. https://doi.org/10.3892/mmr.2019.10115